These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16822956)

  • 1. Impact of portal glucose delivery on glucose metabolism in conscious, unrestrained mice.
    Chueh FY; Malabanan C; McGuinness OP
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1206-11. PubMed ID: 16822956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion.
    Moore MC; Cardin S; Edgerton DS; Farmer B; Neal DW; Lautz M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E226-33. PubMed ID: 14519598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the portal signal during 24-h glucose delivery in unrestrained, conscious rats.
    Ogihara N; Kawamura W; Kasuga K; Hayashi Y; Arakawa H; Kikuchi M
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E932-40. PubMed ID: 14709421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal glucose infusion increases hepatic glycogen deposition in conscious unrestrained rats.
    Cardin S; Emshwiller M; Jackson PA; Snead WL; Hastings J; Edgerton DS; Cherrington AD
    J Appl Physiol (1985); 1999 Oct; 87(4):1470-5. PubMed ID: 10517780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid translocation of hepatic glucokinase in response to intraduodenal glucose infusion and changes in plasma glucose and insulin in conscious rats.
    Chu CA; Fujimoto Y; Igawa K; Grimsby J; Grippo JF; Magnuson MA; Cherrington AD; Shiota M
    Am J Physiol Gastrointest Liver Physiol; 2004 Apr; 286(4):G627-34. PubMed ID: 14656711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the portal signal in a nonsteady hyperglycemic state in conscious dogs.
    Ogihara N; Ebihara S; Kawamura W; Okamoto M; Sakai T; Takiguchi K; Morita T; Uchida R; Matsuyama Y; Hayashi Y; Arakawa Y; Kikuchi M
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E148-55. PubMed ID: 12388150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sources of plasma glucose and liver glycogen in fasted ob/ob mice.
    Turner SM; Linfoot PA; Neese RA; Hellerstein MK
    Acta Diabetol; 2005 Dec; 42(4):187-93. PubMed ID: 16382307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake.
    Grubert JM; Lautz M; Lacy DB; Moore MC; Farmer B; Penaloza A; Cherrington AD; McGuinness OP
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E232-40. PubMed ID: 15755768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery.
    Moore MC; Burish MJ; Farmer B; Neal DW; Pan C; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E845-53. PubMed ID: 12773306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chronic fructose infusion on hepatic metabolism during TPN administration.
    Donmoyer CM; Lacy DB; Zhang Y; Chen SS; McGuinness OP
    Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1151-8. PubMed ID: 12424103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal.
    Dicostanzo CA; Dardevet DP; Neal DW; Lautz M; Allen E; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E9-E16. PubMed ID: 16105863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E380-4. PubMed ID: 18056788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
    Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
    J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of blood glucose concentrations after administration of a glucose solution via the jugular vein and portal vein in cows.
    Braun U; Heusmann B; Camenzind D; Haessig M
    J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):398-400. PubMed ID: 17877578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
    Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
    Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hepatic portal glucose concentration on food intake and metabolism.
    Tordoff MG; Tluczek JP; Friedman MI
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1474-80. PubMed ID: 2690650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia.
    Zangeneh F; Basu R; Shah P; Arora P; Camilleri M; Rizza RA
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E280-6. PubMed ID: 12857674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
    An Z; DiCostanzo CA; Moore MC; Edgerton DS; Dardevet DP; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E300-6. PubMed ID: 18029444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II.
    Fueger PT; Lee-Young RS; Shearer J; Bracy DP; Heikkinen S; Laakso M; Rottman JN; Wasserman DH
    Diabetes; 2007 Oct; 56(10):2476-84. PubMed ID: 17639019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.